You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Patent: 10,308,929


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,308,929
Title:Method of preparing biological material
Abstract: This invention pertains to a method of preparing biological material from a biological sample selected from the group consisting of blood and sputum samples. The method includes the step of altering at least one constitutive characteristic of the biological sample in the presence of a capturing scaffold by adding a lysis buffer containing a solubilising agent and a detergent to the biological sample, for simultaneously inhibiting coagulation of the biological sample; lysing the biological sample to release the biological material from the biological sample, thus making the biological material available; and capturing at least one fraction of the biological material on the capturing scaffold.
Inventor(s): Grobler; Anne Frederica (Potchefstroom, ZA), Levanets; Oksana (Potchefstroom, ZA)
Assignee: North-West University (Potchefstroom, ZA)
Application Number:14/343,019
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive Analysis of the Claims and Patent Landscape for United States Patent 10,308,929

Introduction

Understanding the intricacies of a patent, particularly its claims and the broader patent landscape, is crucial for inventors, businesses, and legal practitioners. This analysis will delve into the specifics of United States Patent 10,308,929, examining its claims, the context within the patent landscape, and the implications of recent developments in patent law and practice.

Patent Claims: An Overview

Patent claims are the heart of any patent application, defining the scope of the invention and what is protected by the patent. For US Patent 10,308,929, it is essential to analyze each claim to understand the invention's boundaries and potential vulnerabilities.

Claim Structure and Scope

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are critical in determining the patent's scope and are often the focus of infringement and validity disputes.
  • Dependent Claims: These claims refer back to and further limit the independent claims. They can provide additional specificity and help in narrowing down the invention to avoid prior art or other patents[2].

Claim Interpretation and Legal Precedents

The interpretation of patent claims is influenced by legal precedents, such as the Festo Corporation v. Shoketsu Kinzoku Kogyo Kabushiki Co. Ltd. case. This case highlighted that narrowing amendments to claims during the prosecution process can significantly limit the scope of the patent claims, invoking prosecution history estoppel and eliminating the doctrine of equivalents[2].

Patent Allowance Rates and Continuations

Understanding the probability of receiving a patent is complex due to the various continuation procedures available. For US Patent 10,308,929, it is important to consider the following:

First-Action Allowance Rate

  • This rate indicates the proportion of progenitor applications allowed without further examination. It provides a snapshot of how quickly and smoothly the initial application process proceeds[1].

Progenitor Allowance Rate

  • This rate reflects the proportion of progenitor applications allowed without any continuation procedure. It helps in assessing the direct success rate of the initial application[1].

Family Allowance Rate

  • This rate includes the outcomes of continuation applications, showing the proportion of progenitor applications that produce at least one patent. This is particularly relevant if the patent in question has undergone multiple continuation procedures[1].

Patent Landscape Analysis

A comprehensive patent landscape analysis is vital for understanding the strategic position of US Patent 10,308,929 within its technology field.

Technology Field and Saturation

  • The patent landscape analysis helps in identifying the level of saturation within the technology field. High saturation can indicate a mature technology area, suggesting the need to pivot to newer inventive spaces[4].

Competitor Analysis

  • Going beyond known competitors, a patent landscape analysis can reveal emerging players and trends in the field. This helps in making informed decisions about R&D investments and patent strategies[4].

Time-Slicing and Trend Analysis

  • Time-slicing the patent data can show the evolution of technologies over time. For example, if a particular technology area shows a significant decrease in patent filings after a certain year, it may indicate a shift in industry focus or the abandonment of that technology[4].

Use of AI Tools in Patent Applications

The increasing use of AI tools in drafting and editing patent applications introduces new complexities:

Accuracy and Review

  • Practitioners must ensure that all documents prepared with AI assistance are thoroughly reviewed to avoid inaccuracies and omissions. The USPTO emphasizes that relying solely on AI tools is not a reasonable inquiry[3].

Disclosure Requirements

  • If AI tools are used in a way that is material to patentability, their use must be disclosed to the USPTO. This includes situations where AI introduces alternative embodiments not conceived by the inventors[3].

Patent Eligibility Under 35 U.S.C. § 101

The eligibility of patent claims under 35 U.S.C. § 101 is a critical aspect, as seen in cases like Electric Power Group, LLC v. Alstom S.A.

Abstract Ideas and Inventive Concepts

  • Claims must go beyond abstract ideas and merely collecting, analyzing, and displaying information. They must include an inventive concept that is not merely conventional or generic technology[5].

Specific Means of Achieving Results

  • The claims should define specific means of achieving the desired results, rather than just stating the desired outcomes. This distinction is crucial in determining patent eligibility[5].

Strategic Insights and Decision-Making

A thorough analysis of the patent claims and landscape provides strategic insights that can guide business and R&D decisions.

Long-Term Technology Planning

  • By identifying areas of high patent saturation, businesses can plan to pivot to newer technology areas, ensuring long-term innovation and competitiveness[4].

Competitive Positioning

  • Understanding the patent landscape helps in positioning the company relative to competitors, identifying gaps, and opportunities for innovation and expansion[4].

Key Takeaways

  • Claim Analysis: Detailed analysis of independent and dependent claims is crucial for understanding the patent's scope and potential vulnerabilities.
  • Patent Allowance Rates: Understanding the different allowance rates helps in assessing the success rate and potential outcomes of patent applications.
  • Patent Landscape: A comprehensive landscape analysis reveals technology trends, competitor activity, and areas of saturation.
  • AI Tools: The use of AI tools requires careful review and disclosure to ensure compliance with USPTO guidelines.
  • Patent Eligibility: Claims must meet the eligibility criteria under 35 U.S.C. § 101, avoiding abstract ideas and ensuring an inventive concept.

FAQs

Q: What is the significance of the first-action allowance rate in patent applications?

A: The first-action allowance rate indicates the proportion of progenitor applications allowed without further examination, providing insight into the efficiency of the initial application process.

Q: How does the use of AI tools impact patent applications?

A: AI tools must be carefully reviewed to ensure accuracy and compliance with USPTO guidelines. Material use of AI tools must be disclosed to avoid potential issues with patentability.

Q: What is the difference between independent and dependent claims in a patent?

A: Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims, providing additional specificity.

Q: Why is patent landscape analysis important for businesses?

A: Patent landscape analysis helps businesses make strategic decisions by identifying technology trends, competitor activity, and areas of saturation, guiding long-term innovation and R&D investments.

Q: What are the key criteria for patent eligibility under 35 U.S.C. § 101?

A: Claims must go beyond abstract ideas and include an inventive concept that is not merely conventional or generic technology, defining specific means of achieving the desired results.

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent?. Retrieved from https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  2. US20110138338A1 - Patent Claims Analysis System and Method. (n.d.). Retrieved from https://patents.google.com/patent/US20110138338A1/en
  3. U.S. Patent Office Issues Additional Guidance on Use of AI Tools. (2024, April 15). Retrieved from https://www.bipc.com/united-states-patent-office-issues-guidance-on-use-of-ai-tools
  4. Patent Landscape Analysis - Uncovering Strategic Insights. (n.d.). Retrieved from https://www.acclaimip.com/patent-landscaping/patent-landscape-analysis-uncovering-strategic-insights/
  5. Electric Power Group, LLC v. Alstom S.A. (2016, August 1). Retrieved from https://cafc.uscourts.gov/opinions-orders/15-1778.opinion.7-28-2016.1.pdf

More… ↓

⤷  Subscribe

Details for Patent 10,308,929

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. PULMOZYME dornase alfa Solution 103532 December 30, 1993 10,308,929 2031-09-06
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.